Cell proliferation and apoptosis in the fusion of human primary and secondary palates.
The markers of cell proliferation (Ki-67) and apoptosis [caspase-3, TdT-mediated biotin-dUTP nick-end labelling (TUNEL)] and the expression of syndecan-1 and heat shock protein 70 (Hsp70) were analyzed immunohistochemically in 11 developing human palates, from developmental weeks 6 to 10. During fusion of the primary palate, the proportion of proliferating cells decreased from 42 to 32% and the proportion of apoptotic cells decreased from 11 to 7% in the medial-edge epithelium. At later stages, the proportions of both types of cells decreased in the ectomesenchyme, except for proliferating cells in its non-condensing part. At developmental weeks 9-10, the epithelial seam in the secondary palate comprised 28% proliferative cells and 5% apoptotic cells. While condensing ectomesenchyme contained more apoptotic cells than proliferating cells, the opposite was observed for the non-condensing ectomesenchyme. Co-expression of syndecan-1 and Hsp70 was detected in cells budding from the epithelial seam. Our study indicates similar principles for human primary palate and secondary palate fusion, and parallel persistence of proliferation and apoptotic activity. While proliferation enables growth and fusion of different palatal primordia, apoptosis results in the removal of of large numbers epithelial cells at the fusion point. The disintegration of seam remnants seems to be executed through the processes of change in protein content and cell migration, probably leading to cell death as their final outcome.
Department of Anatomy, Histology and Embryology, School of Medicine, University of Split, Split, Croatia. katarina.vukojevic@mefst.hr
Katarina
K
Vukojevic
Darko
D
Kero
Josip
J
Novakovic
Danijela
D
Kalibovic Govorko
Mirna
M
Saraga-Babic
D017209:Apoptosis / Q000502:physiology*; D053148:Caspase 3 / Q000378:metabolism*; D049109:Cell Proliferation; D058750:Epithelial-Mesenchymal Transition / Q000502:physiology; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D020287:In Situ Nick-End Labeling; D019394:Ki-67 Antigen / Q000378:metabolism*; D010159:Palate / Q000196:embryology* / Q000254:growth & development / Q000378:metabolism; D053668:Syndecan-1 / Q000378:metabolism*
D018840:HSP70 Heat-Shock Proteins; D019394:Ki-67 Antigen; D053668:Syndecan-1; D053148:Caspase 3